×
0 0 0 0 0 0 -0.0401799100449776 -0.0364317841079461
Stockreport

Allakos Presents Data from its Eosinophilic Gastrointestinal Diseases Program at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting

Allakos, Inc (ALLK)  More Company Research Source: GlobeNewswire
US:NASDAQ Investor Relations: investor.allakos.com/investor-relations
PDF SAN CARLOS, Calif., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ:ALLK), a clinical stage biotechnology company focused on the development of antibodies for the treatment of eosinophil and mast cell related diseases, today announced the presentation of two posters at the American College of Gastroenterology 2018 Annual Scientific Meeting being held in Philadelphia from October 5 to 10, 2018. The following posters are being presented: Siglec-8, a Novel Selective Target for Eosinophilic Gastrointestinal Diseases (EGIDs) Found on Eosinophils and Mast Cells in Human Tissue (P2591)B. Youngblood, E. Brock, C. Bebbington, N. Tomasevic, H. Rasmussen, K. PetersonTuesday, October 9, 2018, 10:30 a.m. - 4:00 p.m. This study examined the number and phenotype of white blood cells isolated from patient biopsies with eosinophilic gastritis (EG) and eosinophilic esophagitis (EoE). The poster concludes that: Siglec-8 is selectively expressed on eosinophils and mast cells at high levels i [Read more]

IMPACT SNAPSHOT EVENT TIME: ALLK
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ALLK alerts
from News Quantified
Opt-in for
ALLK alerts

from News Quantified
Opt-in for
ALLK alerts

from News Quantified